-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PPK50II4MSLtCD9yui/xliJWhYmwehYBsj57OTWFig3cYInlSnM9Ru2/qM7/7fwt rVixjfS1dmmWLcbyFZ4Mbw== 0000891554-00-000409.txt : 20000215 0000891554-00-000409.hdr.sgml : 20000215 ACCESSION NUMBER: 0000891554-00-000409 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SYNSORB BIOTECH INC CENTRAL INDEX KEY: 0001025863 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-52837 FILM NUMBER: 543868 BUSINESS ADDRESS: STREET 1: STE 201 STREET 2: 1204 KENSINGTON RD NW CITY: CALGARY ALBERTA CANA STATE: A0 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ROYAL CANADIAN GROWTH FUND CENTRAL INDEX KEY: 0001055760 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ROYAL TRUST TOWERS STREET 2: DOMINION CENTRE 77 KING ST STE 3900 CITY: TORONTO STATE: A8 ZIP: 00000 SC 13G 1 SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G under the Securities Exchange Act of 1934 Synsorb Biotech Inc. -------------------------------------- (Name of Issuer) Common Shares ------------------------------ (Title of Class of Securities) 87160V10J ----------------- (CUSIP Number) December 31, 1999 --------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ---------------------------- ----------------------------- CUSIP No. 87160V10J 13G Page 2 of 6 Pages - ---------------------------- ----------------------------- - -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Royal Canadian Growth Fund - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)|_| (b)|_| - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION The jurisdiction of organization is Canada - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER N/A --------------------------------------------------------------- NUMBER OF 6. SHARED VOTING POWER SHARES N/A BENEFICIALLY --------------------------------------------------------------- OWNED BY 7. SOLE DISPOSITIVE POWER EACH N/A REPORTING --------------------------------------------------------------- PERSON WITH 8. SHARED DISPOSITIVE POWER N/A - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON N/A - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* |_| - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 N/A - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* 00 - -------------------------------------------------------------------------------- * SEE INSTRUCTIONS BEFORE FILLING OUT! Item 1(a) Name of Issuer: Synsorb Biotech Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 11011 Esso Plaza East Tower 425 1st Street SW Calgary, Alberta T2P 3L8 Item 2(a) Name of Person Filing: Royal Canadian Growth Fund Item 2(b) Address of Principal Business Office or, if None, Residence: Royal Canadian Growth Fund c/o The Royal Trust Company Royal Trust Tower, P.O. Box 7500, Station A 77 King Street West, 6th Floor Toronto, Ontario M5W 1P9 Item 2(c) Citizenship: Canada Item 2(d) Title of Class of Securities: Common Shares Item 2(e) CUSIP Number: 87160V10J Item 3. If this statement is filed pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) |_| Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) |_| Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) |_| Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C.78c). (d) |_| Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C.8a-8). (e) |_| An Investment Adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) |_| An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) |_| A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) |_| A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) |_| A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) |_| Group, in accordance with Section 240.13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Section 240.13d-1(c), Check this box |X|; Item 4. Ownership. (a) Amount beneficially owned: N/A (b) Percent of class: N/A (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote N/A (ii) Shared power to vote or to direct the vote N/A (iii) Sole power to dispose or to direct the disposition of N/A (iv) Shared power to dispose or to direct the disposition of N/A Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. The Royal Trust Company, as trustee, has appointed Royal Mutual Funds Inc. as manager of the Royal Canadian Growth Fund. Accounts with respect to the Fund managed on a discretionary basis are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from, the sale of such securities. No such account holds more than 5 percent of the class. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. N/A Item 8. Identification and Classification of Members of the Group. N/A Item 9. Notice of Dissolution of Group. N/A Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 11, 2000 ----------------------------- (Date) /s/ Jennifer Lederman ----------------------------- (Signature) Jennifer Lederman, Authorized Signing Officer, The Royal Trust Company, as trustee ----------------------------- (Name/Title) -----END PRIVACY-ENHANCED MESSAGE-----